UNSPSC 51283605: Rifametane

This classification denotes an antitubercular agent with the molecular formula C44H60N4O12, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1PUG6262HX, chemically known as rifamycin, 3-(((1-(diethylamino)ethylidene)hydrazono)methyl)- but more generally known as rifametane, which bears U.S. National Institutes of Health Compound Identifier 9571071. The European Medicines Agency schedules Rifametane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10306MIG.

UNSPSC 51283605 Rifametane is a Commodity code that in state and local procurement covers pharmaceutical products and related medical supplies, though recent solicitation activity shows minimal direct demand for rifametane itself and instead reflects broader purchasing patterns for naloxone, generic pharmaceuticals, OTC products, and emergency medical consumables. State and local governments soliciting under or near this code are acquiring pre-positioned emergency response inventory, pharmacy benefit program supplies, and first-aid materials for health departments, fire rescue divisions, and HHS agencies. The issuing bodies include county health departments (Seminole County, Florida), city fire and rescue services (City of Tampa), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Recent solicitation activity shows a mix of direct county and city procurement alongside cooperative purchasing mechanisms that consolidate demand across state and local participants.

Activity concentrates in Florida and Minnesota, with a notable multistate component through MMCAP (serving Minnesota and Oregon among others) and Texas HHS. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2026, seeking 1,900 units annually with quarterly delivery), the City of Tampa's invitation to bid for medical and first aid supplies for the Tampa Fire Department Rescue Division (26P00145, due March 13, 2026, estimated contract value $700,000.00, designated as sheltered market for certified Small Local Business Enterprises with a 5 percent SLBE bid discount), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026, serving participating state and local facilities). The Texas HHS Commission also issued a Request for Information (RFI HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and GPO channels, signaling emerging interest in alternative pharmacy supply models among state buyers.